EDAP to Present at Jefferies Global Healthcare Conference in London
Rhea-AI Summary
EDAP (Nasdaq: EDAP) will present at the Jefferies Global Healthcare Conference in London on Tuesday, November 18, 2025. Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings from 4:30–4:55 pm GMT at the Waldorf – Aldwych, Entresol Level.
A live webcast will be available on the conference webcast page and an archived replay will be accessible in the company’s Investors section.
Positive
- None.
Negative
- None.
News Market Reaction 2 Alerts
On the day this news was published, EDAP gained 1.50%, reflecting a mild positive market reaction. Argus tracked a peak move of +3.4% during that session. Argus tracked a trough of -4.8% from its starting point during tracking. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $1M to the company's valuation, bringing the market cap to $81M at that time.
Data tracked by StockTitan Argus on the day of publication.
EDAP to Present at Jefferies Global Healthcare Conference in London
Company to Present and Host 1x1 Investor Meetings on Tuesday, November 18th, 2025
AUSTIN, Texas, November 4, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present and host 1x1 investor meetings at the upcoming Jefferies Global Healthcare Conference, which is being held November 18-20, 2025, in London, United Kingdom.
Date: Tuesday, November 18th
Presentation Time: 4:30-4:55 pm GMT
Format: Presentation and 1x1 investor meetings
Location: Waldorf – Aldwych, Entresol Level
Webcast: https://wsw.com/webcast/jeff332/edap/1817998
The live and archived webcast of the presentation can be accessed in the Investors section of the Company’s website here.
About EDAP TMS SA
A recognized leader in robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP introduced the Focal One® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit https://focalone.com/.
Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
legal@focalone.com
Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
jfraunces@lifesciadvisors.com
FAQ
When is EDAP (Nasdaq: EDAP) presenting at the Jefferies Global Healthcare Conference in 2025?
Who will represent EDAP at the Jefferies Global Healthcare Conference on November 18, 2025?
How can investors watch EDAP's Jefferies conference presentation on November 18, 2025?
Where is EDAP presenting during the Jefferies Global Healthcare Conference in London?
Will EDAP host one-on-one investor meetings at the Jefferies Global Healthcare Conference?
What is the webcast URL for EDAP's Jefferies Global Healthcare Conference presentation?
